Overview of New Onset Diabetes after Transplantation Induced by Tacrolimus
Fatmah Abdullah Bakhdar · Journal of Pharmaceutical Research International · 2021
Tacrolimus is an important therapy in the post-transplant immunosuppressant regimen. However, it is responsible for the highest incidence of a specific type of diabetes called new onset diabetes after transplantation (NODAT). The dangers of NODAT are not limited to cardiovascular...
Open access
Research Article
10.9734/jpri/2020/v32i3931020